IRWD · Ironwood Pharmaceuticals Inc · Documents
$3.63
+0.07 (+1.97%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$588.25M
Shares
165.24M
Volume · Oct 20
1.64M
Avg daily vol (3M)
1.99M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | On October 12, 2026, Ironwood Pharmaceuticals appointed Chief Commercial Officer Tammi Gaskins as CEO effective January 1, 2027, succeeding Tom McCourt, who retires after 17 years and will remain a director. | 2026-10-16 | 2026-10-12 | |
| 10-Q | — | 2026-08-06 | 2026-06-30 | |
| 8-K | — | 2026-08-06 | — | |
| Investor Event Transcript | — | 2026-06-30 | — | |
| 8-K | — | 2026-06-18 | 2026-06-16 | |
| 8-K | — | 2026-06-15 | — | |
| Investor Event Transcript | — | 2026-06-04 | 2026-06-30 | |
| 8-K/A | — | 2026-05-21 | 2026-05-08 | |
| 8-K | — | 2026-05-13 | 2026-05-08 | |
| 8-K | — | 2026-05-07 | — | |
| 10-Q | — | 2026-05-07 | 2026-03-31 | |
| DEF 14A | — | 2026-04-28 | 2026-06-16 | |
| ARS | — | 2026-04-28 | 2025-12-31 | |
| DEFA14A | — | 2026-04-28 | — | |
| 8-K | — | 2026-03-11 | 2026-03-10 | |
| 10-K | — | 2026-02-26 | 2025-12-31 | |
| 8-K | — | 2026-02-25 | — | |
| 8-K | — | 2026-01-02 | — | |
| 8-K | — | 2025-12-23 | 2025-12-18 | |
| 8-K | — | 2025-11-26 | 2025-11-25 | |
| 8-K | — | 2025-11-10 | — | |
| 10-Q | — | 2025-11-10 | 2025-09-30 | |
| 8-K | — | 2025-10-10 | 2025-10-07 | |
| 8-K | — | 2025-09-03 | 2025-08-29 | |
| 10-Q | — | 2025-08-11 | 2025-06-30 | |
| 8-K | — | 2025-08-07 | — | |
| 8-K | — | 2025-07-10 | 2025-07-03 | |
| 8-K | — | 2025-06-12 | 2025-06-10 | |
| 8-K | — | 2025-06-03 | 2025-05-28 | |
| 10-Q | — | 2025-05-12 | 2025-03-31 | |
| 8-K | — | 2025-05-07 | — | |
| DEF 14A | — | 2025-04-28 | 2025-06-10 | |
| ARS | — | 2025-04-28 | 2024-12-31 | |
| DEFA14A | — | 2025-04-28 | — | |
| 8-K | — | 2025-04-25 | — | |
| 8-K | — | 2025-04-14 | — | |
| 10-K | — | 2025-03-31 | 2024-12-31 | |
| 8-K | — | 2025-03-27 | 2025-03-21 | |
| NT 10-K | — | 2025-03-03 | 2024-12-31 | |
| 8-K | — | 2025-02-27 | — | |
| 8-K | — | 2025-01-29 | 2025-01-17 | |
| 8-K | — | 2024-12-05 | 2024-12-02 | |
| 8-K | — | 2024-11-12 | 2024-11-06 | |
| 8-K | — | 2024-11-07 | — | |
| 10-Q | — | 2024-11-07 | 2024-09-30 | |
| 8-K | — | 2024-09-30 | 2024-09-27 | |
| 10-Q | — | 2024-08-08 | 2024-06-30 | |
| 8-K | — | 2024-08-08 | — | |
| 8-K | — | 2024-06-21 | — | |
| 8-K | — | 2024-06-20 | — |
Showing 1–50 of 133 filings
Key facts
CIK
1446847
CUSIP
46333X108
13F (30d)
18 filings
18 filers
Visit website
Investor relations